Catechol-o-methyltransferase (COMT) and Proline Dehydrogenase (PRODH) mRNAs in the Dorsolateral Prefrontal Cortex in Schizophrenia, Bipolar Disorder, and Major Depression

Synapse

Volumn 51, Issue 2, 2004, Pages 112-118

  Tunbridge, Elizabeth ^a   Burnet, Philip W J ^a   Sodhi, Monsheel S ^a   Harrison, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dopamine; Human brain; mRNA; RT PCR; Velo cardio facial syndrome

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; MESSENGER RNA; PROLINE DEHYDROGENASE;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CHROMOSOME 22Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEMIZYGOSITY; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR DEPRESSION; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; VELOCARDIOFACIAL SYNDROME;

ADULT; ALANINE; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; BLOTTING, SOUTHERN; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHROMOSOMES, HUMAN, PAIR 22; CYCLOPHILINS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; GLYCINE; HUMANS; MALE; METHIONINE; MIDDLE AGED; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; PROLINE OXIDASE; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA; VALINE;

EID: 0348141708     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10286     Document Type: Article

References (39)

1. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. 2003. COMT genotype and dopamine regulation in the human brain. J Neurosci 23:2008-2013.
2. Basset AS, Chow EWC. 1999. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biol Psychiatry 46:882-891.
3. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O'Donovan MC. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152-161.
4. 2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age. Neurosci Lett 178:85-89.
5. Chakravarti A. 2002. A compelling genetic hypothesis for a complex disease: PRODH2/DGCR6 variation leads to schizophrenia susceptibility. Proc Natl Acad Sci USA 99:4755-4756.
6. Cohen SM, Nadler JV. 1997a. Proline-induced potentiation of glutamate transmission. Brain Res 761:271-282.
7. Cohen SM, Nadler JV. 1997b. Proline-induced inhibition of glutamate release in hippocampal area CA1. Brain Res 769:333-339.
8. Cross AJ, Crow TJ, Killpack WS, Longden A, Owen F, Riley GJ. 1978. The activities of brain dopamine-β-hydroxylase and catechol-O-methyltransferase in schizophrenics and controls. Psychopharmacology 59:117-121.
9. Dunham I, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, et al. 1999. The DNA sequence of human chromosome 22. Nature 402:489-495.
10. 7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr Res 57:15-26.
11. Eastwood SL, Burnet PWJ, Harrison PJ. 1997. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Mol Brain Res 44:92-98.
12. 108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
13. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:9991-9996.
14. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. 1999. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434-439.
15. Harrison PJ, Owen MJ. 2003. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361:417-419.
16. Jacquet H, Raux G, Thibault F, Hecketsweiler B, Houy E, Demilly C, Haouzir S, Allio G, Fouldrin G, Drouin V, Bou J, Petit M, Campion D, Frebourg T. 2002. PRODH mutations and hyperprolinaemia in a subset of schizophrenic patients. Hum Mol Genet 11:2243-2249.
17. Joober R. 2002. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin card sorting test. Arch Gen Psychiatry 59:662.
18. Karayiorgou M, Morris MA, Morrow B, Shprintzen J, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarkis SE, Pulver AE, Housman DE. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92:7612-7616.
19. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45: 77-84.
20. Karoum F, Chrapusta SJ, Egan MF. 1994. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two-pool model. J Neurochem 63:972-979.
21. Koetsier PA, Schorr J, Doerfler W. 1993. A rapid optimised protocol for downward alkaline Southern blotting of DNA. Biotechniques 15:260-262.
22. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyl transferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
23. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC, Collier DA. 2000. Family-based linkage disequilibrium mapping using SNP marker haplotype: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 5:1178-1189.
24. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, Taskinen J. 1995. Kinetics of soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
25. Lui H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, Lenane M, Robertson B, Wijsman E, Rapoport JL, Gogos JA, Karayiorgou M. 2002. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 99:3717-3722.
26. Mannisto PT, Kaakkola S. 1999. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
27. Matsumoto M, Shannon Weickert C, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR. 2003a. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116: 127-137.
28. Matsumoto M, Shannon Weickert C, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. 2003b. Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 28:1521-1530.
29. Murphy KC. 2002. Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426-430.
30. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56: 940-945.
31. Norton N, Kirov G, Zammit S, Jones G, Jones S, Owen R, Krawczak M, Williams NM, O'Donovan MC, Owen MJ. 2002. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. Am J Med Genet 114:491-496.
32. Olney JW, Farber NB. 1995. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007.
33. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, Wolyniec PS, Kucherlapati R. 1994. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182:476-478.
34. Scambler PJ. 2000. The 22q11 deletion syndromes. Hum Mol Genet 9:2421-2426.
35. Shifman S, Bronstein M, Sternfeld M, Pisánte-Shalom A, Lev-Leh man E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Bechmann JS, Yakir B, Risch N, Zak NB, Darvasi A. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296-1302.
36. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. 1992. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141-142.
37. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. 2000. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 44:151-155.
38. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. 2001. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825-844.
39. Weinshilboum RM, Otterness DM, Szumlanski CL. 1999. Methylation pharmacogenetics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39:19-52.